127 related articles for article (PubMed ID: 29958636)
41. Metformin treatment reduces temozolomide resistance of glioblastoma cells.
Yang SH; Li S; Lu G; Xue H; Kim DH; Zhu JJ; Liu Y
Oncotarget; 2016 Nov; 7(48):78787-78803. PubMed ID: 27791206
[TBL] [Abstract][Full Text] [Related]
42. PDGF receptor alpha inhibition induces apoptosis in glioblastoma cancer stem cells refractory to anti-Notch and anti-EGFR treatment.
Cenciarelli C; Marei HE; Zonfrillo M; Pierimarchi P; Paldino E; Casalbore P; Felsani A; Vescovi AL; Maira G; Mangiola A
Mol Cancer; 2014 Nov; 13():247. PubMed ID: 25380967
[TBL] [Abstract][Full Text] [Related]
43. Integrin inhibitor cilengitide for the treatment of glioblastoma: a brief overview of current clinical results.
Scaringi C; Minniti G; Caporello P; Enrici RM
Anticancer Res; 2012 Oct; 32(10):4213-23. PubMed ID: 23060541
[TBL] [Abstract][Full Text] [Related]
44. The antipsychotic drugs sertindole and pimozide block erg3, a human brain K(+) channel.
Kang J; Chen XL; Rampe D
Biochem Biophys Res Commun; 2001 Aug; 286(3):499-504. PubMed ID: 11511086
[TBL] [Abstract][Full Text] [Related]
45. Targeting glioblastoma stem cells (GSCs) with peroxisome proliferator-activated receptor gamma (PPARγ) ligands.
Im CN
IUBMB Life; 2016 Mar; 68(3):173-7. PubMed ID: 26818439
[TBL] [Abstract][Full Text] [Related]
46. Aptamer targeting EGFRvIII mutant hampers its constitutive autophosphorylation and affects migration, invasion and proliferation of glioblastoma cells.
Camorani S; Crescenzi E; Colecchia D; Carpentieri A; Amoresano A; Fedele M; Chiariello M; Cerchia L
Oncotarget; 2015 Nov; 6(35):37570-87. PubMed ID: 26461476
[TBL] [Abstract][Full Text] [Related]
47. BC3EE2,9B, a synthetic carbazole derivative, upregulates autophagy and synergistically sensitizes human GBM8901 glioblastoma cells to temozolomide.
Chen CM; Syu JP; Way TD; Huang LJ; Kuo SC; Lin CT; Lin CL
Int J Mol Med; 2015 Nov; 36(5):1244-52. PubMed ID: 26329365
[TBL] [Abstract][Full Text] [Related]
48. Schizophrenia.
McIntosh A; Lawrie S
Clin Evid; 2004 Dec; (12):1502-33. PubMed ID: 15865730
[No Abstract] [Full Text] [Related]
49. Small molecules targeting histone demethylase genes (KDMs) inhibit growth of temozolomide-resistant glioblastoma cells.
Banelli B; Daga A; Forlani A; Allemanni G; Marubbi D; Pistillo MP; Profumo A; Romani M
Oncotarget; 2017 May; 8(21):34896-34910. PubMed ID: 28432280
[TBL] [Abstract][Full Text] [Related]
50. Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating Cells.
Venugopal C; Hallett R; Vora P; Manoranjan B; Mahendram S; Qazi MA; McFarlane N; Subapanditha M; Nolte SM; Singh M; Bakhshinyan D; Garg N; Vijayakumar T; Lach B; Provias JP; Reddy K; Murty NK; Doble BW; Bhatia M; Hassell JA; Singh SK
Clin Cancer Res; 2015 Dec; 21(23):5324-37. PubMed ID: 26152745
[TBL] [Abstract][Full Text] [Related]
51. CD133 and DNA-PK regulate MDR1 via the PI3K- or Akt-NF-κB pathway in multidrug-resistant glioblastoma cells in vitro.
Xi G; Hayes E; Lewis R; Ichi S; Mania-Farnell B; Shim K; Takao T; Allender E; Mayanil CS; Tomita T
Oncogene; 2016 Jan; 35(2):241-50. PubMed ID: 25823028
[TBL] [Abstract][Full Text] [Related]
52. A Synthetic Cell-Penetrating Dominant-Negative ATF5 Peptide Exerts Anticancer Activity against a Broad Spectrum of Treatment-Resistant Cancers.
Karpel-Massler G; Horst BA; Shu C; Chau L; Tsujiuchi T; Bruce JN; Canoll P; Greene LA; Angelastro JM; Siegelin MD
Clin Cancer Res; 2016 Sep; 22(18):4698-711. PubMed ID: 27126996
[TBL] [Abstract][Full Text] [Related]
53. Efficacy of pimozide augmentation for clozapine partial responders with schizophrenia.
Gunduz-Bruce H; Oliver S; Gueorguieva R; Forselius-Bielen K; D'Souza DC; Zimolo Z; Tek C; Kaliora S; Ray S; Petrides G
Schizophr Res; 2013 Feb; 143(2-3):344-7. PubMed ID: 23219861
[TBL] [Abstract][Full Text] [Related]
54. HDAC6 promotes cell proliferation and confers resistance to temozolomide in glioblastoma.
Wang Z; Hu P; Tang F; Lian H; Chen X; Zhang Y; He X; Liu W; Xie C
Cancer Lett; 2016 Aug; 379(1):134-42. PubMed ID: 27267806
[TBL] [Abstract][Full Text] [Related]
55. Fetal exposure to pimozide: a case report.
Bjarnason NH; Rode L; Dalhoff K
J Reprod Med; 2006 May; 51(5):443-4. PubMed ID: 16779996
[TBL] [Abstract][Full Text] [Related]
56. Schizophrenia.
Nadeem Z; McIntosh A; Lawrie S
Clin Evid; 2003 Dec; (10):1208-37. PubMed ID: 15555143
[No Abstract] [Full Text] [Related]
57. Use of pimozide in the Pisa syndrome.
Suzuki E; Kanba S; Nibuya M; Shintani F; Kinoshita N; Yagi G; Asai M
Am J Psychiatry; 1992 Aug; 149(8):1114-5. PubMed ID: 1322069
[No Abstract] [Full Text] [Related]
58. A pilot study of pimozide in schizophrenia.
Smythies JR; Beaton JM
J Psychiatr Res; 1974; 11():71-2. PubMed ID: 4618288
[No Abstract] [Full Text] [Related]
59. [The treatment of different psychopathologic conditions with Pimozide(ORAP)].
Munkvad I
Nord Psykiatr Tidsskr; 1971; 25(4):347-9. PubMed ID: 5154119
[No Abstract] [Full Text] [Related]
60. Molecular mechanisms of anti-psychotic drugs for improvement of cancer treatment.
Hendouei N; Saghafi F; Shadfar F; Hosseinimehr SJ
Eur J Pharmacol; 2019 Aug; 856():172402. PubMed ID: 31108054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
